TY - JOUR
T1 - Effects of methadone on corrected Q-T interval prolongation in critically ill children
AU - Heath, Travis S.
AU - Greenberg, Rachel G.
AU - Hupp, Susan R.
AU - Turner, David A.
AU - Hornik, Christoph P.
AU - Zimmerman, Kanecia O.
N1 - Funding Information:
Correspondence Travis Heath, PharmD; travis.heath@duke.edu Disclosures The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. Dr Greenberg was supported by National Institutes of Health (NIH) T32 training grants 5T32HD43728-10 and 5T32HD043029-13. Dr Hornik receives salary support for research from the National Center for Advancing Translational Sciences of the NIH (UL1TR001117). Dr Zimmerman is funded by KL2TR001115-03 from the Duke Clinical and Translational Science Awards. The authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Publisher Copyright:
© Published by the Pediatric Pharmacy Advocacy Group. All rights reserved.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - OBJECTIVES This study aimed to determine the association between methadone use and corrected Q-T interval (QTc) prolongation in critically ill children METHODS A retrospective cohort study of critically ill children receiving methadone at a tertiary care pediatric hospital was conducted. Patients younger than 19 years who had been admitted to the intensive care unit between January 1, 2009, and June 21, 2013, who had received methadone while inpatients, and who had had electrocardiograms (ECGs) performed within 30 days before and after methadone initiation were included. The primary outcome was the net change in QTc interval between baseline and postmethadone ECGs. Secondary outcomes included percent change in QTc interval and the proportion of patients whose QTc intervals changed from normal to prolonged following methadone initiation. We also evaluated potential predictors of QTc interval prolongation, including age, sex, admission diagnosis category, exposure to other QTc-prolonging medications, presence of congenital heart disease or known arrhythmias, and methadone daily dose and route of administration. RESULTS Sixty-four patients met the inclusion criteria. The median (25th, 75th percentiles) change in QTc interval following methadone initiation was −8 msec (−34, 13.5 msec; p = 0.19). Five patients (8%) had a baseline normal QTc interval that became prolonged after methadone initiation. We identified no statistically significant predictors of QTc prolongation after methadone initiation. CONCLUSIONS In this dedicated pediatric safety study, methadone initiation did not result in prolongation of the QTc interval. Although these findings suggest methadone initiation may not have a substantial effect of QTc prolongation in critically ill children, a controlled, prospective evaluation in this population remains warranted.
AB - OBJECTIVES This study aimed to determine the association between methadone use and corrected Q-T interval (QTc) prolongation in critically ill children METHODS A retrospective cohort study of critically ill children receiving methadone at a tertiary care pediatric hospital was conducted. Patients younger than 19 years who had been admitted to the intensive care unit between January 1, 2009, and June 21, 2013, who had received methadone while inpatients, and who had had electrocardiograms (ECGs) performed within 30 days before and after methadone initiation were included. The primary outcome was the net change in QTc interval between baseline and postmethadone ECGs. Secondary outcomes included percent change in QTc interval and the proportion of patients whose QTc intervals changed from normal to prolonged following methadone initiation. We also evaluated potential predictors of QTc interval prolongation, including age, sex, admission diagnosis category, exposure to other QTc-prolonging medications, presence of congenital heart disease or known arrhythmias, and methadone daily dose and route of administration. RESULTS Sixty-four patients met the inclusion criteria. The median (25th, 75th percentiles) change in QTc interval following methadone initiation was −8 msec (−34, 13.5 msec; p = 0.19). Five patients (8%) had a baseline normal QTc interval that became prolonged after methadone initiation. We identified no statistically significant predictors of QTc prolongation after methadone initiation. CONCLUSIONS In this dedicated pediatric safety study, methadone initiation did not result in prolongation of the QTc interval. Although these findings suggest methadone initiation may not have a substantial effect of QTc prolongation in critically ill children, a controlled, prospective evaluation in this population remains warranted.
KW - Adverse drug effect
KW - Electrocardiogram
KW - Methadone
KW - Pediatrics
KW - QTc interval
KW - QTc prolongation
KW - Torsades de pointes
UR - http://www.scopus.com/inward/record.url?scp=85046878866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046878866&partnerID=8YFLogxK
U2 - 10.5863/1551-6776-23.2.119
DO - 10.5863/1551-6776-23.2.119
M3 - Article
C2 - 29720913
AN - SCOPUS:85046878866
SN - 1551-6776
VL - 23
SP - 119
EP - 124
JO - Journal of Pediatric Pharmacology and Therapeutics
JF - Journal of Pediatric Pharmacology and Therapeutics
IS - 2
ER -